Skip to content

Kısa ve Öz Haber Haber247

24/7 haber gündem piyasalar son dakika

  • İletişim

FDA staff focus on safety of Astellas bladder drug

04 Nisan 2012 by Haber247

WASHINGTON (Reuters) – Drugs reviewers said Astellas Pharma Inc’s treatment for an overactive bladder worked, but they raised concerns about liver and heart safety issues.


Reuters: Health News

Categories DÜNYA Tags Astellas, bladder, drug, focus, safety, staff
Post navigation
Schwartzel ready to show Masters win was no fluke
First Marines in Australia under new security deal
© 2022 Kısa ve Öz Haber Haber247 • Powered by GeneratePress